Open Opportunities

Research Project Development Teams (PDTs) are groups of experienced senior faculty located on each of the Indiana CTSI campuses who will connect you with resources, collaboration opportunities, and small (typically up to $15,000) awards for preliminary or additional data. Each PDT is designed around a common research theme.

There are biostatisticians and regulatory experts on each team, and other experts are added, as needed, to the team to when your application is discussed. You will have access to the expertise and knowledge you need all in one place.

The PDT application process is contingent on the stage of the project. You have selected the application process for pilot funding from the PDTs for a first time external submission. If you are seeking pilot funding prior to an external resubmission please use Research Project Development Teams (PDTs):  Project Revision

Research Project Development Teams (PDTs) are groups of experienced senior faculty located on each of the Indiana CTSI campuses who will connect you with resources, collaboration opportunities, and small (typically up to $15,000) awards for preliminary or additional data. Each PDT is designed around a common research theme.

There are biostatisticians and regulatory experts on each team, and other experts are added, as needed, to the team to when your application is discussed. You will have access to the expertise and knowledge you need all in one place.

The PDT application process is contingent on the stage of the project. You have selected the application process for pilot funding from the PDTs for an external resubmission.  If you are seeking pilot funding prior a first time external submission please use Research Project Development Teams (PDTs):  Project Refinement.

This funding opportunity announcement invites applications from all Indiana CTSI investigators with a full-time academic appointment for up to $50,000 to support innovative research work that is in scope and aligned with the research activities of the IUSM-Purdue TREAT-AD Center. These include (but are not limited to):

• Bioinformatic analyses and drug target hypothesis generation within neuroinflammatory pathways
• Target validation studies for proposed drug targets
• Innovative chemical biology and cellular pharmacology studies for proposed targets that provide insights to disease initiation and progression
• Structural biology or biophysical studies on proteins proposed as drug targets
• De-novo drug design approaches for proposed targets
• Novel PET ligands and supporting CSF biomarkers for preclinical studies and clinical trials, etc.

The Biomedical Research Grant program is open to all IU School of Medicine (IUSM) faculty that are full-time, regardless of tenure status, having an appointment of Assistant/Associate/Full Professor and Assistant/Associate/Full Scientist. In general, two categories of research projects will benefit from this program: 1) research projects of investigators new to IUSM who do not yet have extramural funding and who need support to acquire the preliminary data necessary to compete for extramural funding; 2) research projects of established IUSM investigators who are between funding periods from extramural sources.

Applications are considered small grants and should have a maximum requested amount of $50,000 and be limited to one (1) year duration

The IU Simon Comprehensive Cancer Center is providing an opportunity to fund cancer focused PI-directed applications to the National Institutes of Health that have been reviewed once and missed the NIH pay line and have a high potential for obtaining external funding. The goal is to increase the cancer focused NIH funding base. Non-NCI targeted applications should have significant cancer relevance.

Investigators wishing to apply to this funding mechanism must first submit their project to the IU External Resubmission Grant opportunity for funding consideration. If the project is not funded at the University level, an investigator can submit the project to the Cancer Center’s Near-Miss initiative for funding consideration.

Investigators wishing to apply to this funding mechanism must first submit a draft cover letter (letter of intent) for approval by the Cancer Center’s Executive Committee before working with a Coordinator to submit a full application. Once approved, the link for submitting the online application will be sent.

Maximum allowable amount for R01, R42 and R44 grants is $50K with P01 and SPORE funding amounts evaluated on a case-by-case basis.

IU Simon Comprehensive Cancer Center, Office of Community Outreach and Engagement is inviting collaborative proposals for implementing evidence-based cancer related programs within the community. Proposals should focus on the cancer burden in Indiana. The program should have an evaluation component and priority will be given to one of the major cancer burdens in Indiana including lung, breast, colon, pancreas, prostate and cervical. We are particularly interested in programs that can lower risk behaviors related to cancers which drive cancer incidence and morbidity. Of particular interest are community-led programs that will increase our reach or understanding of the underserved populations in Indiana. The project must be co-led by an CC faculty member and community advocate or partner.

The duration of this funding is one year, and the budget should not exceed $15,000.

The objective of the new Indiana CTSI Clinical & Translational Science (CTS) pilot grant mechanism is to initiate or continue translational science projects that help identify translational methods and processes relevant across a range of diseases, treatments, and interventions. The key objective of the projects should be to develop methodological innovations and/or produce crosscutting solutions for common and persistent challenges to reduce, remove, or bypass significant bottlenecks across the continuum of translation.

Applications to this program are limited to a total of $40,000 and are 12 months (1 year) in duration. There will be no ability to apply for a no cost extension with this new grant.

The submission link to use in WebCAMP will be sent after the LOI is submitted.

The Indiana CTSI Community Health Partnerships (CHeP) Trailblazer Award supports collaborative, community-engaged research projects focused on topics that have potential to improve health, examine social determinants of health (SDoH), or enhance health equity for Indiana residents. Eligible projects will propose to: (1) implement exploratory research that has the potential to identify or reduce health inequities, or impact SDoH; (2) evaluate a program that has the potential to improve health equity or impact SDOH; or (3) implement and do a preliminary evaluation of a health-related program. There must be both 1) a university lead and 2) a community lead for the project, and both partners must currently work in an Indiana-based institution or organization.

The Indiana CTSI Community Health Partnerships (CHeP) is soliciting proposals for the development of community-university partnerships to improve health, examine social determinants of health (SDoH), or enhance health equity, to result in future collaborative research proposals. The award can be used to establish new partnerships or to strengthen/expand existing community-university partnerships to solve critical health problems affecting Indiana residents. This award will not fund research pilot projects; instead, it will fund activities to help develop partnerships between organizations that have potential to later engage in joint research projects to address health, health equity, or SDoH. The expected outcome of this award is the development of a future research proposal for opportunities such as the Community Health Partnerships Trailblazer Award (Trailblazer Award). Examples of partnership development activities we are interested in funding include meetings, conferences, travel expenses, stakeholder interviews, and quality improvement assessments.

There must be at least one university-based partner and one community-based partner. All partners must currently be employed in Indiana-based institutions or organizations.

Awards will be up to $5,000 for two years to allow for partnership growth and collaborative grant proposal development.

This Executive Associate Dean for Research (EADR) sponsored program is intended to support large, collaborative, interdisciplinary grants including, but not limited to, program project grants (P01s), center grants (P30s, P50s, P60s), and cooperative agreements (U54s). The goal of this initiative is to bring together faculty of Indiana University School of Medicine (IUSM) to collaborate and develop novel concepts that advance the mission and research goals of IUSM. These funds must be used for experiments to generate data to support the grant application. Support for this program is dependent on the availability of funds from the EADR.

Please see RFA linked below for details.

The IUSM Research Enhancement Program is designed to stimulate research productivity at the statewide Centers for Medical Education (regional campuses) including the Bloomington Medical Sciences Program. This does not include the IU Indianapolis campus. All full-time Center/Medical Sciences faculty, regardless of tenure status, having an appointment of Assistant/Associate/Full Professor or Assistant/Associate/Full Scientist at time of submission, are eligible to apply for a Research Enhancement Grant. Primary appointment must be in the School of Medicine. Faculty in visiting ranks are not eligible for funding through this mechanism.

Applications are considered small grants and should have a maximum requested amount of $50,000 and be limited to one (1) year duration